Dose Conversion: Dexmethylphenidate ER 30mg to Vyvanse
There is no established direct dose equivalency between dexmethylphenidate ER 30mg and lisdexamfetamine (Vyvanse), as these are different medication classes (methylphenidate vs amphetamine) with distinct mechanisms and cannot be converted using a simple ratio.
Key Pharmacological Differences
These medications belong to fundamentally different stimulant classes:
- Dexmethylphenidate ER 30mg: The active d-isomer of methylphenidate, dosed at half the typical d,l-methylphenidate dose due to single isomer formulation 1
- Vyvanse (lisdexamfetamine): A prodrug that converts to dextroamphetamine after oral administration 2
Why Direct Conversion Is Not Possible
The 2026 Lancet Psychiatry network meta-analysis examining dose-effect relationships found that amphetamines and methylphenidate have different dose-response curves 3. Specifically:
- Methylphenidate reached peak efficacy at approximately 45 mg/day (immediate-release equivalent)
- Lisdexamfetamine showed a dose-effect relationship up to approximately 55 mg/day where effects plateaued 3
These distinct pharmacodynamic profiles mean you cannot apply a mathematical conversion factor between the two medications.
Clinical Approach to Switching
When transitioning from dexmethylphenidate ER 30mg to Vyvanse, start with Vyvanse 30mg and titrate based on clinical response 2. This approach is supported by:
- Vyvanse is available in 10,20,30,40,50,60, and 70 mg doses 2
- The therapeutic range for lisdexamfetamine is 30-70 mg daily 2
- Starting at 30mg provides a conservative mid-range starting point that can be adjusted upward or downward
Important Caveats
- Duration of action differs: Dexmethylphenidate ER provides 10-12 hours of benefit 1, while lisdexamfetamine provides 11-13 hours 1, 4
- Onset differs: Lisdexamfetamine has approximately 2-hour onset due to prodrug activation 1, which may affect morning symptom control
- Side effect profiles vary: Lisdexamfetamine may have higher rates of insomnia compared to methylphenidate formulations 5
- Individual response is unpredictable: Studies show subgroups of patients respond differently to amphetamine versus methylphenidate classes, with some responding better to one class over the other 1
Monitor closely during the first 2-4 weeks after switching, as amphetamine-based medications may require several weeks to reach full therapeutic effect 1.